185 related articles for article (PubMed ID: 37916491)
1. Insight into RNA-based Therapies for Ovarian Cancer.
Keyvani V; Mahmoudian RA; Mollazadeh S; Kheradmand N; Ghorbani E; Khazaei M; Saeed Al-Hayawi I; Hassanian SM; Ferns GA; Avan A; Anvari K
Curr Pharm Des; 2023; 29(34):2692-2701. PubMed ID: 37916491
[TBL] [Abstract][Full Text] [Related]
2. Delivery of nucleic acid therapeutics for cancer immunotherapy.
Zhou S; Chen W; Cole J; Zhu G
Med Drug Discov; 2020 Jun; 6():. PubMed ID: 34337382
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in mRNA cancer vaccines.
Yao R; Xie C; Xia X
Hum Vaccin Immunother; 2024 Dec; 20(1):2307187. PubMed ID: 38282471
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutics: response and resistance in ovarian cancer.
Zamarin D
Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s16-s21. PubMed ID: 31462544
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer.
Saman S; Srivastava N; Yasir M; Chauhan I
Curr Cancer Drug Targets; 2024; 24(2):142-166. PubMed ID: 37642226
[TBL] [Abstract][Full Text] [Related]
6. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer.
Malla R; Srilatha M; Farran B; Nagaraju GP
Mol Ther; 2024 Jan; 32(1):13-31. PubMed ID: 37919901
[TBL] [Abstract][Full Text] [Related]
7. Advancements in small interfering RNAs therapy for acute lymphoblastic leukemia: promising results and future perspectives.
Rastgar A; Kheyrandish S; Vahidi M; Heidari R; Ghorbani M
Mol Biol Rep; 2024 Jun; 51(1):737. PubMed ID: 38874790
[TBL] [Abstract][Full Text] [Related]
8. Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent-loaded nanoparticles.
Siddiquee T; Bhaskaran NA; Nathani K; Sawarkar SP
Phytother Res; 2024 May; ():. PubMed ID: 38806412
[TBL] [Abstract][Full Text] [Related]
9. Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics for cancer.
Yadav S; Shekhawat M; Jahagirdar D; Kumar Sharma N
Cancer Biol Med; 2017 Aug; 14(3):242-253. PubMed ID: 28884041
[TBL] [Abstract][Full Text] [Related]
10. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.
Neill B; Romero AR; Fenton OS
ACS Appl Bio Mater; 2023 Nov; ():. PubMed ID: 37930174
[TBL] [Abstract][Full Text] [Related]
11. Unlocking the Potential of RNA Nanoparticles: A Breakthrough Approach to Overcoming Challenges in Colon Cancer Treatment.
Karati D; Mukherjee S; Basu B; Garala K; Dutta A; G Prajapati B; Bhattacharya S
Curr Pharm Biotechnol; 2024 Mar; ():. PubMed ID: 38482614
[TBL] [Abstract][Full Text] [Related]
12. Advancing cancer treatment:
Yang X; Liang Y; Tong S
Front Mol Biosci; 2023; 10():1297413. PubMed ID: 38234581
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics: the good, the bad, and the future.
Magaña Rodriguez JR; Guerra-Rebollo M; Borrós S; Fornaguera C
Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38700815
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid-based vaccine for ovarian cancer cells; bench to bedside.
Al-Hawary SIS; Jasim SA; Hjazi A; Oghenemaro EF; Kaur I; Kumar A; Al-Ani AM; Alwaily ER; Redhee AH; Mustafa YF
Cell Biochem Funct; 2024 Mar; 42(2):e3978. PubMed ID: 38515237
[TBL] [Abstract][Full Text] [Related]
15. Nucleic acid vaccines-based therapy for triple-negative breast cancer: A new paradigm in tumor immunotherapy arena.
Saleh RO; Ibrahim FM; Pallathadka H; Kaur I; Ahmad I; Ali SHJ; Redhee AH; Ghildiyal P; Jawad MA; Alsaadi SB
Cell Biochem Funct; 2024 Apr; 42(3):e3992. PubMed ID: 38551221
[TBL] [Abstract][Full Text] [Related]
16. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm.
Beigi A; Naghib SM; Matini A; Tajabadi M; Mozafari MR
Curr Gene Ther; 2024 May; ():. PubMed ID: 38778601
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers: Exploring the Potential of Oligonucleotide Delivery.
Alsaidan OA
Curr Drug Deliv; 2024 Jun; ():. PubMed ID: 38918987
[TBL] [Abstract][Full Text] [Related]
18. Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system.
Hao L; Boehnke N; Elledge SK; Harzallah NS; Zhao RT; Cai E; Feng YX; Neaher S; Fleming HE; Gupta PB; Hammond PT; Bhatia SN
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307802121. PubMed ID: 38437557
[TBL] [Abstract][Full Text] [Related]
19. Current approaches in smart nano-inspired drug delivery: A narrative review.
Boppana SH; Kutikuppala LVS; Sharma S; C M; Rangari G; Misra AK; Kandi V; Mishra S; Singh PK; Rabaan AA; Mohapatra RK; Kudrat-E-Zahan M
Health Sci Rep; 2024 Apr; 7(4):e2065. PubMed ID: 38660006
[TBL] [Abstract][Full Text] [Related]
20. Assembling the RNA therapeutics toolbox.
Teng M; Xia ZJ; Lo N; Daud K; He HH
Med Rev (2021); 2024 Apr; 4(2):110-128. PubMed ID: 38680684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
